Show Notes
Dermot from Ireland started experiencing chronic fatigue syndrome symptoms after undergoing cancer treatment in 2018. His health declined significantly after a potential COVID-19 infection in early 2020, leading to ongoing health challenges such as nausea, fatigue, and difficulty breathing. Despite undergoing various tests and consultations, the exact cause of their symptoms remained unclear. After experiencing a brief improvement in 2022, they identified chronic fatigue mixed with irritable bowel syndrome as potential causes of their ongoing health issues and are exploring treatment options including LDN which has helpped enormously.
More from The LDN Radio Show About Low Dose Naltrexone
Explore the latest advancements in Low Dose Naltrexone (LDN) research with the LDN Research Trust Radio Show. Hosted by Linda Elsegood, this episode delves into viral infections, Long COVID, mold toxicity, cancer, and longevity. Discover insights from featured books and learn about ongoing research initiatives, including a survey on LDN and anti-aging.
Join host Linda Elsegood and Crystal Matte, PharmD on the LDN Radio as they explore the transformative power of Low-Dose Naltrexone (LDN). Discover how LDN is revolutionizing treatment for various chronic conditions, from autoimmune diseases and inflammation to pain management and hormonal imbalances. Hear inspiring patient testimonials and gain insights from pharmacists dedicated to this innovative therapy.
Join host Linda Elsegood on the LDN Radio Show as she interviews Rachel, a woman with over 25 years of experience living with multiple sclerosis. Rachel shares her transformative journey with Low Dose Naltrexone (LDN), detailing significant symptom relief and medication reduction. Discover how LDN has positively impacted her life, addressing issues like double vision, spasticity, and incontinence.
This LDN Radio Show episode features Joyce Risa Kleinman sharing her daughter Jenni’s inspiring journey with ALS. Jenni, a naturopathic physician, found significant relief and extended quality of life through low-dose naltrexone (LDN) after her diagnosis. The discussion explores the challenges of LDN adoption in medicine and highlights Jenni’s remarkable resilience and advocacy.
Explore a personalized approach to Low-Dose Naltrexone (LDN) with Dr. JJ Allen on the LDN Radio Show. Discover his journey from engineering to pharmacy, advocating for foundational health, lifestyle changes, and evidence-based nutraceuticals. Learn about optimizing key nutrients and the nuanced titration of LDN for autoimmune conditions and long COVID.